Emergent BioSolutions CEO Testifies Before House Oversight Committee About 15M Ruined VaccinesEmergent BioSolutions' executives were grilled in a Capitol Hill hearing Wednesday. Lawmakers wanted answers on what went wrong at the Baltimore facility when products that would have been used for 15 million doses of the Johnson & Johnson COVID-19 vaccine became contaminated.
Emergent Says Plan Coming Within Days To Fix J&J COVID Vaccine Mistake At Baltimore PlantEmergent BioSolutions said it hopes to respond to federal regulators within days on how to resolve the problems at its East Baltimore plant.
Emergent BioSolutions CEO Dumped $11M Of Stock Before Announcement About 15M Botched Doses Of Johnson & Johnson Vaccine Was Made PublicEmergent BioSciences' stock lost more than half of its value since the disclosure that it ruined as many as 15 million doses of Johnson & Johnson's Covid-19 vaccine at its Baltimore plant. But the company's CEO dumped more than $11 million worth of stock ahead of the stock's massive decline.
FDA Completes Inspection Of J&J Vaccine Maker Emergent BioSolutions, Cites Concerns Over Cross-Contamination, SanitationThe U.S. Food and Drug Administration has completed its inspection of the Baltimore-based Johnson & Johnson vaccine maker Emergent BioSolutions Tuesday and "cited a number of observations concerning whether the facility’s processes met our requirements and standards."
Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation UnderwayEmergent BioSolutions, the Baltimore, Maryland-based company manufacturing the Johnson & Johnson coronavirus vaccines, was asked to stop manufacturing COVID-19 related products, while the Food & Drug Administration continues its investigation into quality control issues at the plant that ruined 15 million potential doses of the vaccine.
Baltimore City Health Officials Say They Will Switch To Moderna Doses While Johnson & Johnson On PauseBaltimore City will be pause doses of Johnson & Johnson until further notice following guidance from state health officials, the CDC and the FDA.
Amid Calls For Transparency, Emergent CEO Says Workers Did Not Accidentally Mix Johnson & Johnson, AstraZeneca VaccinesRobert Kramer, the CEO of Emergent BioSolutions, said in an interview with CNBC that he wanted to clear up “misunderstandings and misconceptions” about what happened at the company’s Baltimore facility last month when millions of Johnson & Johnson vaccine doses were reportedly ruined.